Predictive and prognostic value of microtubule-associated protein-tau and classes I to IV β-tubulin isotypes in locally advanced breast cancer

被引：0
|
作者：
Tibau, A. [1 ]
Lopez Vilaro, L. [2 ]
Anguera, G. [1 ]
Virgili, A. [1 ]
Perez-Olabarria, M. [2 ]
Vazquez, T. [2 ]
Gich, I. [3 ]
Alonso, C. [1 ]
Ojeda, B. [1 ]
Ramon y Cajal, T. [1 ]
Murata, P. [1 ]
Enrique, L. [2 ]
Escuin, D. [4 ]
Barnadas, A. [1 ]
机构：
[1] Hosp Santa Creu & Sant Pau, Dept Med Oncol, Barcelona, Spain
[2] Hosp Santa Creu & Sant Pau, Dept Pathol, Barcelona, Spain
[3] Hosp Santa Creu & Sant Pau, Dept Epidemiol, Barcelona, Spain
[4] Hosp Santa Creu & Sant Pau, Inst Invest Biomed, Barcelona, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)30151-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
266
引用
收藏
页码：S48 / S48
页数：1
相关论文
共 46 条
  • [21] Increased expression of the microtubule-associated protein tau is associated with better outcome in breast cancer.
    Baquero, M. T.
    Gustavson, M.
    Giltnane, J.
    Camp, R. L.
    Rimm, D. L.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S261 - S262
  • [22] Stathmin expression and its relationship to microtubule-associated protein tau and outcome in breast cancer
    Baquero, Maria T.
    Hanna, Jason A.
    Neumeister, Veronique
    Cheng, Huan
    Molinaro, Annette M.
    Harris, Lyndsay N.
    Rimm, David L.
    CANCER, 2012, 118 (19) : 4660 - 4669
  • [23] Assessment of microtubule-associated protein (MAP)-Tau expression as a predictive and prognostic marker in TACT; a trial assessing substitution of sequential docetaxel for FEC as adjuvant chemotherapy for early breast cancer
    Irshad, S.
    Gillett, C.
    Pinder, S. E.
    A'Hern, R. P.
    Dowsett, M.
    Ellis, I. O.
    Bartlett, J. M. S.
    Bliss, J. M.
    Hanby, A.
    Johnston, S.
    Barrett-Lee, P.
    Ellis, P.
    Tutt, A.
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 144 (02) : 331 - 341
  • [24] Assessment of microtubule-associated protein (MAP)-Tau expression as a predictive and prognostic marker in TACT; a trial assessing substitution of sequential docetaxel for FEC as adjuvant chemotherapy for early breast cancer
    S. Irshad
    C. Gillett
    S. E. Pinder
    R. P. A’Hern
    M. Dowsett
    I. O. Ellis
    J. M. S. Bartlett
    J. M. Bliss
    A. Hanby
    S. Johnston
    P. Barrett-Lee
    P. Ellis
    A. Tutt
    Breast Cancer Research and Treatment, 2014, 144 : 331 - 341
  • [25] Microtubule-associated protein tau correlates with estrogen receptor status but not with in vitro paclitaxel sensitivity in primary breast cancer
    Honig, A.
    Gehrmann, M.
    Kranke, P.
    Keller, D.
    Engel, J. B.
    Hengstler, J.
    Schmidt, M.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2014, 35 (05) : 503 - 507
  • [26] Predictive and prognostic value of molecular genetic markers in the treatment of locally advanced breast cancer (BC)
    Semiglazova, T.
    Krovorot'ko, P.
    Bus'ko, E.
    Novikov, S.
    Klimenko, V.
    Turkevich, E.
    Belyaeva, A.
    Semiglazov, V.
    Imyanitov, E.
    Semiglazov, V.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S291 - S291
  • [27] Development of two novel benzoylphenylurea sulfur analogues and evidence that the microtubule-associated protein tau is predictive of their activity in pancreatic cancer
    Jimeno, Antonio
    Hallur, Gurulingappa
    Chan, Audrey
    Zhang, Xiangfeng
    Cusatis, George
    Chan, Fonda
    Shah, Preeti
    Chen, Rongbing
    Hamel, Ernest
    Garrett-Mayer, Elizabeth
    Khan, Saeed
    Hidalgo, Manuel
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (05) : 1509 - 1516
  • [28] Microtubule Associated Protein Tau Expression as a Predictive and Prognostic Marker in a Trial Assessing Sequential Docetaxel as Adjuvant Chemotherapy for Early Breast Cancer (TACT).
    Tutt, A.
    Gillett, C.
    Pinder, S.
    A'Hern, R. P.
    Dowsett, M.
    Ellis, I. O.
    Bartlett, J.
    Bliss, J. M.
    Johnston, S.
    Ellis, P.
    CANCER RESEARCH, 2009, 69 (24) : 523S - 523S
  • [29] Prognostic and predictive value of changes in tumour cell proliferation in locally advanced breast cancer primarily treated with doxorubicin
    Aas, T
    Geisler, S
    Helle, H
    Borresen-Dale, AL
    Lonning, PE
    Akslen, LA
    ONCOLOGY REPORTS, 2005, 13 (03) : 525 - 530
  • [30] Microtubule associated protein Tau is a predictive marker and modulator of response to paclitaxel-containing preoperative chemotherapy in breast cancer
    Pusztai, L
    Rouzier, R
    Rajan, R
    Stec, J
    Buzdar, AU
    Ayers, M
    Ross, JS
    Hess, KR
    Buchholz, TA
    Kuerer, HM
    Symmans, FW
    Hortobagyi, GN
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S23 - S24
12345